Novo Nordisk proceeds to sue Hims over Wegovy copycats despite HIMS halting sales. Pre-market: NVO +7% HIMS -20%

    https://www.cnbc.com/2026/02/09/novo-nordisk-sues-hims-hers-compounded-obesity-drugs.html

    Posted by callsonreddit

    1 Comment

    Leave A Reply
    Share via